Ordinary medicine : extraordinary treatments, longer lives, and where to draw the line / Sharon R. Kaufman.
By: Kaufman, Sharon R.
Series: Publisher: Durham ; London : Duke University Press, 2015Description: xiii, 314 pages ; 23 cm.Content type: text Media type: unmediated Carrier type: volumeISBN: 9780822358886 (pbk. : alk. paper).Subject(s): Medical care -- United States | Medical ethics -- United States | Medical care, Cost of -- United States | Longevity -- United StatesGenre/Form: Print books.DDC classification: 362.10973| Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|
| On Shelf | RA395.A3 K385 2015 (Browse shelf) | Available | AU0000000004658 |
Browsing Alfaisal University Shelves , Shelving location: On Shelf Close shelf browser
|
|
|
|
|
|
|
||
| RA395.A3 I567 2017 McCarthy's introduction to health care delivery : a primer for pharmacists / | RA395.A3 J327 2016 Health care reform and American politics : what everyone needs to know / | RA395.A3 K353 2019 More than medicine : the broken promise of American health / | RA395.A3 K385 2015 Ordinary medicine : extraordinary treatments, longer lives, and where to draw the line / | RA395.A3 K7593 2015 Healthcare reform in America : a reference handbook / | RA395.A3 L66 2015 Health policymaking in the united states / | RA395.A3 M393 2015 Health policy analysis : an interdisciplinary approach / |
Includes bibliographical references (pages 285-305) and index.
Diagnosing Twenty-First-Century health care -- The quandary and unexamined ordinariness of Twenty-First-Century medicine -- Ordinary medicine in our aging society: the dilemma of longevity -- The chain of health care drivers -- The medical-industrial complex I: evidence-based medicine, the biomedical -- Economy, and the ascendance of clinical trials -- The medical-industrial complex II: access, industry, and the clinical trials -- Phenomenon -- "Reimbursement is critical for everything": medicare and the ethics of managing life -- Medicine's changing means and ends -- Standard and necessary treatments: the changing means and ends of technology -- Family matters: kidneys and new forms of care -- Influencing the character of the future: prognosis, risk, and time left -- For whose benefit? Our shared quandary -- Toward a new social contract?.